
Any femtech company worth their hormones cares about their users’ privacy. However, for privacy to really matter, it must be met by concrete actions that keep advertisers’ hands out of the data jar.
The recent investigation by The Observer reveals tracking tools embedded into NHS websites in the UK, which collected browsing information and shared it with Facebook for years. What is going on?
The internet is built on advertising revenues, dependent on collecting as much personal data as possible. The reality is that companies developing online advertising technologies devise ever more sophisticated ways to collect and exploit your customers’ most sensitive information. It is hard to avoid and femtech and health apps are falling into this trap and falling foul of regulators.
The list of fines slapped on the industry is growing globally: Flo, BetterHelp, GoodRX and most recently Premom in the USA; Bounty, Emma’s Diary, Doctissimo in the UK and EU. The Information Commissioner’s Office (ICO) in the UK is considering investigating the NHS case.
It is unfortunately quite often the case that women’s safety and wellbeing is not at the centre of commercial data gathering on their health. The impact on women is unique when it comes to reproductive rights such as menstruation, sex, pregnancy, IVF, birth, miscarriage, abortion and menopause.
Most blatantly, as in the example of Bounty and Emma’s Diary, some companies sell customer information they have collected themselves – often sensitive – to data brokers, who then use this information to profile people and sell those profiles back to advertisers, decision makers and political parties, often without the user’s knowledge or informed consent.
This could be exploited in endless ways: by targeting women desperate to conceive or manage menopause symptoms with unnecessary or fake products; digitally following a woman who has lost her baby with adverts for baby products and raising safety concerns around which organisations have a woman’s home address, phone number or precise location data and why.
Beyond selling databases packed with personal info, there are layers of complexity when it comes to extracting valuable personal data at a technical level through third party cookies, pixels, analytics tools and software development kits (SDKs).
Online trackers, commonly known as cookies or pixels, placed on websites by adtech companies collect personal data and track activity across the web also for the purposes of profiling. This landed Doctissimo a fine, a leading health website in France.
Third party cookies are thankfully on the way out, mainly due to web browsers fighting back. Firefox and Safari already block most third party cookies for cross-site tracking, and Chrome is slowly catching up with the trend.
That’s good news for customers, but tracking capabilities are also embedded deep into many popular analytics tools and developer toolkits used by companies to build their products, such as the “Meta pixel”, a piece of code a developer puts on their own website to track users activity on that website and help with targeting or retargeting users with advertising on Facebook.
This is tripping companies up when it comes to their legal commitments not to share data and it appears this is what happened in the NHS case through using the Meta pixel.
In 2019, the Federal Trade Commission (FTC) in the US found that the Flo Period & Ovulation Tracker disclosed data on millions of customers to Facebook, Google, Fabric and AppsFlyer for analytics and marketing and did not limit what these companies could do with the information.
The Wall Street Journal reported that this information included a unique advertising identifier, that can be matched to a device or profile as well as the user’s intention to get pregnant, and when the user was having her period.
The FTC found BetterHelp, an online counselling app whose users are reportedly mostly young and female, continually broke their privacy promises by sharing data extensively with Facebook, monetising consumers’ sensitive health information to target them and others with advertisements.
Part of the FTC complaint against Premom detailed how the company requested access to a customer’s location in order to pair a bluetooth thermometer, and then shared that precise location data with two analytics firms based in China, which could then sell that information onto others.
In the case of Premom the FTC said their actions were likely to cause “stigma, embarrassment, or emotional distress, and may also affect their ability to obtain or retain employment, housing, health insurance, disability insurance, or other services.”
It could be argued that the online advertising ecosystem is stacked against consumer-facing companies, cornered into using “industry standard” tools that are extractive and exploitative. So what are you going to do about it?
Don’t just change your privacy policy. This is not just about data protection but also unfair consumer practices, the cornering of the market by big tech and looking closely at reforming the online advertising industry.
A gender perspective needs to be one of the cornerstones of these reforms and it is going to take an industry wide effort to push back against the well documented harms.
Femtech can get ahead by raising the bar and exploring alternatives to the current extractive status quo. Refuse, loudly, to be a source for data brokers. Remove the Meta Pixel and look deep into analytics tools and SDKs to check what data is being shared with who and for what purpose. Seek help from regulators. For example, the ICO offers a regulatory sandbox in order to test and embed privacy by design into products and services.
The femtech industry is revolutionising women’s healthcare. I am sure she can revolutionise the online advertising industry as well.
Lucy Purdon is a senior tech policy fellow at Mozilla Foundation, where she focuses on driving legal and policy reforms related to the online advertising industry and its impact on women. She was previously policy director at Privacy International, a UK charity challenging governments and companies who exploit our data for power and profit.
Newsletter
Sign up for free weekly updates
The latest femtech news, research and investment, straight to your inbox.









